|
Industry Groups in UK Update Insurance Guidance for Phase I Clinical Trials
UK sponsors of Phase I clinical trials should take out adequate insurance policies in order to accelerate ethics committee review processes and assure volunteers they will be compensated if they suffer an injury or adverse event as a result of the study, according to a new industry best practice guideline.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives